Normal skin Normal skin tolerates daily copper peptide application well
PubMed Staresinic, M., Sebecic, B., Patrlj, L., Jadrijevic, S., Suknaic, S., Perovic, D., Aralica, G., Zarkovic, N., Borovic, S., Srdjak, M., Hajdar, S., Kopljar, M., Batelja, L., Boban-Blagaic, A., Turcic, I., Amic, F., Ruenzi, E., Rucman, R., Seiwerth, S., Sikiric, P
Lee Rosebush, PharmD, JD, chair of the American Academy of Peptide Medicine, told the committee during the public comment period that under FDA regulations for bulk compounding, theres no requirement to prove safety or efficacy. Few Rules for Compounded Drugs None of the peptides have been approved for human use or have undergone rigorous clinical trials in humans
Standardized dosing, sterility certification, and verified purity are not bureaucratic formalities they are the difference between a clinical tool and an unknown substance
Graf reported that DSIP reduced corticotropin-releasing-factor-induced corticosterone release in rats, suggesting an interaction with the hypothalamic-pituitary-adrenal axis (PMID 2995861)